• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952808300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Chest Tightness/Pressure (2463)
Event Date 05/08/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr.: the device was not received for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause was unable to be determined.(b)(4).
 
Event Description
Same case as mdr id #: 2134265-2015-08077, 2134265-2015-08075 and 2134265-2015-08074.(b)(6).It was reported that myocardial infarction (mi) occurred.In (b)(6) 2015, index procedure was performed.Target lesion #1 was a de novo lesion located in the mid right coronary artery (rca) with 80% stenosis and was 20 mm long with a reference vessel diameter of 2.75mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00x24mm promus premier everolimus-eluting platinum chromium coronary stent.Visual estimate was with 0% residual stenosis.Target lesion #2 was a de novo lesion located in the proximal rca with 90% stenosis and was 10mm long with a reference vessel diameter of 3.00mm.Target lesion #2 was treated with pre-dilatation and placement of a 3.00x32mm promus premier everolimus-eluting platinum chromium coronary stent.Visual estimate was with 0% residual stenosis.Target lesion #3 was located in the proximal rca with 70% stenosis and was 20mm long with a reference vessel diameter of 3.00mm.Target lesion #3 was treated with pre-dilatation and placement of a 3.00x32mm promus premier everolimus-eluting platinum chromium coronary stent.Post-dilatation was performed with 15% residual stenosis.Target lesion #4 was a de novo lesion located in the mid lad with 70% stenosis and was 25mm long with a reference vessel diameter of 3.75 mm.Target lesion #4 was treated with pre-dilatation and placement of a 2.75x28mm promus premier everolimus-eluting platinum chromium coronary stent.Visual estimate was with 0% residual stenosis.One day post index procedure, the patient experienced the event of elevated cardiac enzymes which was categorized as a myocardial infarction and prolonged the patient's hospitalization.The patient experienced chest tightness while walking to the restroom and was thought to possibly be related to a side branch compromise.Signs and symptoms were relieved by lan.The patient was started on lose-dose amlodipine.On the next day, the event was considered resolved and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2015, the signs and symptoms experienced by the patient were relieved by long-acting nitrates(lan).Specifically, the patient received isosorbide dinitrate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5258908
MDR Text Key32450418
Report Number2134265-2015-08078
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/14/2016
Device Model NumberH7493952808300
Device Catalogue Number39528-0830
Device Lot Number17618192
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-